CytomX Therapeutics Inc
NASDAQ:CTMX

Watchlist Manager
CytomX Therapeutics Inc Logo
CytomX Therapeutics Inc
NASDAQ:CTMX
Watchlist
Price: 0.89 USD 2.71% Market Closed
Market Cap: 69.7m USD
Have any thoughts about
CytomX Therapeutics Inc?
Write Note

Balance Sheet

Balance Sheet Decomposition
CytomX Therapeutics Inc

Current Assets 124.2m
Cash & Short-Term Investments 117.6m
Receivables 3.4m
Other Current Assets 3.2m
Non-Current Assets 14.8m
PP&E 12.1m
Intangibles 1.6m
Other Non-Current Assets 1.1m
Current Liabilities 119.2m
Accounts Payable 1.4m
Accrued Liabilities 21.7m
Other Current Liabilities 96.1m
Non-Current Liabilities 43.2m
Other Non-Current Liabilities 43.2m

Balance Sheet
CytomX Therapeutics Inc

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
64
60
105
178
248
188
192
206
194
17
Cash Equivalents
64
60
105
178
248
188
192
206
194
17
Short-Term Investments
0
127
77
197
189
108
124
100
0
157
Total Receivables
2
1
2
10
0
0
1
1
36
3
Accounts Receivables
2
1
2
10
0
0
1
1
36
3
Other Receivables
0
0
0
0
0
0
0
0
0
0
Other Current Assets
1
2
4
4
9
7
7
4
8
5
Total Current Assets
67
190
188
389
446
303
324
310
237
183
PP&E Net
3
4
4
4
7
33
29
25
21
16
PP&E Gross
3
4
4
4
7
33
29
25
21
16
Accumulated Depreciation
2
3
4
5
7
9
11
14
14
15
Intangible Assets
2
2
2
2
2
1
1
1
1
1
Goodwill
1
1
1
1
1
1
1
1
1
1
Other Long-Term Assets
1
1
4
2
2
3
3
2
1
1
Other Assets
1
1
1
1
1
1
1
1
1
1
Total Assets
73
N/A
197
+170%
199
+1%
398
+100%
457
+15%
341
-25%
359
+5%
339
-5%
261
-23%
202
-23%
Liabilities
Accounts Payable
2
5
7
4
5
4
3
3
3
1
Accrued Liabilities
2
5
9
16
27
30
23
34
27
22
Short-Term Debt
0
0
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
1
0
0
0
0
0
0
0
0
0
Other Current Liabilities
6
6
20
41
66
51
75
41
123
132
Total Current Liabilities
11
16
36
61
98
86
101
78
153
156
Long-Term Debt
2
0
0
0
0
0
0
0
0
0
Deferred Income Tax
1
1
1
0
0
0
0
0
0
0
Other Liabilities
62
55
84
267
228
205
208
262
194
93
Total Liabilities
75
N/A
71
-5%
121
+70%
328
+172%
326
0%
290
-11%
309
+6%
340
+10%
347
+2%
249
-28%
Equity
Common Stock
77
0
0
0
0
0
0
0
0
0
Retained Earnings
78
118
176
220
315
417
450
624
723
723
Additional Paid In Capital
0
244
255
290
446
468
500
623
637
676
Other Equity
0
0
0
0
0
0
0
0
0
0
Total Equity
2
N/A
126
N/A
79
-38%
70
-11%
131
+87%
51
-61%
50
-3%
1
N/A
86
-17 060%
47
+45%
Total Liabilities & Equity
73
N/A
197
+170%
199
+1%
398
+100%
457
+15%
341
-25%
359
+5%
339
-5%
261
-23%
202
-23%
Shares Outstanding
Common Shares Outstanding
35
36
37
39
45
46
48
65
66
67

See Also

Discover More